These 14 blockbuster new drugs will be approved in China in 2021 Frontier Bio intends to raise 2 billion yuan on the Science and Technology Innovation Board! Aconin R&D investment and sales performanc ...
The research reveals that IBS patients with genetic defects in carbohydrate digestion have a better response to particular dietary interventions. This could lead to tailored treatments for IBS, ...